73 related articles for article (PubMed ID: 19198274)
1. [The informative value of markers in the evaluation of the severity of endotoxicosis in pyonecrotic lesions of the lower limbs in diabetic patients].
Gazin IK
Klin Lab Diagn; 2008 Dec; (12):17-20. PubMed ID: 19198274
[No Abstract] [Full Text] [Related]
2. [Pathophysiological aspects of endotoxicosis complicated with purulent infection of the foot and correction of endotoxicosis with conventional treatment and with application of ozonized physiological solution in patients suffering from diabetes mellitus].
Gazin IK
Patol Fiziol Eksp Ter; 2008; (4):23-5. PubMed ID: 19198268
[TBL] [Abstract][Full Text] [Related]
3. [Criteria for intoxication in the evaluation of severity of endotoxicosis, the efficiency of ozone therapy and traditional treatment in patients with diabetes mellitus complicated by pyonecrotic lesions of the lower extremities].
Gazin IK
Klin Lab Diagn; 2008 Jun; (6):21-3. PubMed ID: 18724429
[TBL] [Abstract][Full Text] [Related]
4. Circulating endothelial progenitor cells and angiogenic factors in diabetes complicated diabetic foot and without foot complications.
Kulwas A; Drela E; Jundziłł W; Góralczyk B; Ruszkowska-Ciastek B; Rość D
J Diabetes Complications; 2015 Jul; 29(5):686-90. PubMed ID: 25872462
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of pyonecrotic complications in diabetic macroangiopathy].
Dibirov MD; Gadzhimuradov RU; Evseev IuN; Novosel'tsev OS
Khirurgiia (Mosk); 2001; (3):29-33. PubMed ID: 11400448
[TBL] [Abstract][Full Text] [Related]
6. [Correction of the glicemia level in elderly and senile patients with diabetes mellitus, operated for purulent-necrotic foot lesion].
Ivashchenko VV; Kolkin Iag; Koval'chuk VS; Ivashchenko AV
Klin Khir; 2005 Aug; (8):51-4. PubMed ID: 16445063
[TBL] [Abstract][Full Text] [Related]
7. [Central hemodynamics during conduction anesthesia in patients with pyonecrotic forms of the diabetic foot].
Orudzheva SA; Zviagin AA; Kurochkina AI
Anesteziol Reanimatol; 2005; (3):15-7. PubMed ID: 16076038
[TBL] [Abstract][Full Text] [Related]
8. [Central hemodynamics during epidural anesthesia in patients with pyonecrotic forms of diabetic foot].
Orudzheva SA; Chistov AS; Zviagin AA; Sashurina LP
Anesteziol Reanimatol; 2002; (3):39-41. PubMed ID: 12221875
[TBL] [Abstract][Full Text] [Related]
9. Marked reduction in serum high-density lipoprotein cholesterol concentrations in a woman with acute inflammation due to diabetic gangrene.
Kobayashi J; Tateishi S; Maruyama T; Kudoh A; Murano S
Clin Chim Acta; 2003 Sep; 335(1-2):33-8. PubMed ID: 12927682
[TBL] [Abstract][Full Text] [Related]
10. Morphometric analysis of skin microvasculature in the diabetic foot.
Yusof MI; Al-Astani AD; Jaafar H; Rashid FA
Singapore Med J; 2008 Feb; 49(2):100-4. PubMed ID: 18301834
[TBL] [Abstract][Full Text] [Related]
11. Diabetic foot tendinopathy: abnormalities in the flexor plantar tendons in patients with diabetes mellitus.
Ramirez LC; Raskin P
J Diabetes Complications; 1998; 12(6):337-9. PubMed ID: 9877468
[No Abstract] [Full Text] [Related]
12. Foot bone mass and analysis of calcium metabolism in diabetic patients affected by severe neuropathy.
Barbaro D; Orsini P; Lapi P; Turco A; Pasquini C
Minerva Endocrinol; 2008 Dec; 33(4):283-8. PubMed ID: 18923365
[TBL] [Abstract][Full Text] [Related]
13. [Cytokine profile and fibrinogen level in blood plasma in diabetic foot under the action of heparin].
Harbarchuk OI
Ukr Biokhim Zh (1999); 2000; 72(3):118-9. PubMed ID: 11200464
[TBL] [Abstract][Full Text] [Related]
14. Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection.
Uzun G; Onem Y; Hatipoglu M; Turhan V; Mutluoglu M; Ay H
Scand J Infect Dis; 2013 Jan; 45(1):73-6. PubMed ID: 22746695
[TBL] [Abstract][Full Text] [Related]
15. [Experience in the use of vessel due F (sulodexide) in patients with suppurative-necrotic forms of diabetic foot without critical ischemia].
Svetukhin AM; Zemlianoĭ AB; Orudzheva SA; Titova MI; Rudneva VG; Elagina LV; Pavlova MV; Terekhova RP; Bozh'eva EI; Makhmudova LS
Ter Arkh; 2001; 73(4):31-3. PubMed ID: 11494443
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous oxygen pressure as a predictor for short-term survival in patients with type 2 diabetes and foot ulcers: a comparison with ankle-brachial index and toe blood pressure.
Fagher K; Katzman P; Löndahl M
Acta Diabetol; 2018 Aug; 55(8):781-788. PubMed ID: 29707757
[TBL] [Abstract][Full Text] [Related]
17. Hemorheological disturbances as a marker of diabetic foot syndrome deterioration.
Khodabandehlou T; Le Dévéhat C
Clin Hemorheol Microcirc; 2004; 30(3-4):219-23. PubMed ID: 15258346
[TBL] [Abstract][Full Text] [Related]
18. [Regional anesthesia and timely treatment for neuropathy in patients with pyonecrotic forms of the diabetic foot].
Orudzheva SA; Zviagin AA; Simonenkov AP; Tsvetkov VO; Kurochkina AI; Klenskiĭ SK; Braverman IB
Anesteziol Reanimatol; 2005; (2):35-7. PubMed ID: 15938094
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study.
Jansen RB; Christensen TM; Bülow J; Rørdam L; Holstein PE; Jørgensen NR; Svendsen OL
J Diabetes Complications; 2018 Feb; 32(2):164-170. PubMed ID: 29196119
[TBL] [Abstract][Full Text] [Related]
20. [Pathogenetical and clinical features of the course of pyonecrotic complications of diabetic foot].
Petrova VV; Spesivtsev IuA; Larionova VI; Egorenkov MV; Smirnov GA; Remezov AV; Chub VIu
Vestn Khir Im I I Grek; 2010; 169(2):121-4. PubMed ID: 20552808
[No Abstract] [Full Text] [Related]
[Next] [New Search]
